Differentiating iron-deficiency anemia from other types (e.g., thalassemia trait, vitamin B12 or folate deficiency, anemia of inflammation) through laboratory biomarkers such as ferritin, transferrin saturation, or CRP could help identify which subtypes are most harmful in the context of preeclampsia and tailor interventions accordingly. The gene discussed is CRP; the disease is Iron deficiency anemia.